Eli Lilly's Retatrutide, a new GLP-1 drug, achieved an unprecedented 28.7% average body weight loss in trials, outperforming Zepbound. It also significantly reduced knee pain. Some side effects and dropouts were noted.
CMS controversially canceled its "Making Care Primary" program, meant to improve care and reduce costs. While CMS cites $750M savings, a CBO report questioned its fiscal impact, sparking frustration among providers concerned about rural healthcare access.
Time-restricted feeding (TRF) significantly reduces Crohn's disease activity by 40% and pain by 50% in 12 weeks, improving inflammation & gut bacteria. It also aids type 2 diabetes & weight loss, yet research shows potential risks like fertility issues or hair loss. Consult a doctor before changes.
Longevity doctor Michael Aziz discusses anti-aging peptides like Epitalon and GHK-Cu, which may extend telomeres and maintain stem cells. He also highlights Semaglutide's metabolic benefits and the risks of unregulated peptide markets.
New research reveals that clinical depression often precedes Parkinson’s and Lewy body dementia by years, serving as a biological indicator of early neurodegenerative brain changes rather than mere psychological distress.
A 20-year NIH-funded randomized trial found "speed of processing" cognitive training significantly reduced dementia risk by 25% in older adults, including Alzheimer's, making it the only intervention to show such long-term protective effects.
A study using hair samples spanning a century uncovered how environmental regulations, particularly the EPA's, dramatically reduced childhood lead exposure from sources like leaded gas. This significantly improved public health, reversing historical impacts like reduced IQ and psychological issues.
MIT researchers are using noninvasive transcranial focused ultrasound to stimulate deep brain regions, aiming to identify the neural circuits that generate conscious experience and solve the 'hard problem' of the mind.
Explore cutting-edge hair loss treatments from Korea and the US, including exosome therapy, stem cell research, and personalized science-backed solutions like light therapy and supplements.
Cancer cells package immunosuppressive PD-L1 into sEVs via UBL3, hindering immunotherapy. Researchers found widely used statins can block this process, offering a new strategy to enhance immune checkpoint therapies by reducing circulating immunosuppressive PD-L1.
New research suggests low-dose THC combined with an anti-inflammatory medicine could protect memory and reduce mental retardation in Alzheimer's, a disease affecting millions and previously resistant to COX-2 preventions, offering a faster potential therapy.
Prenatal BPA exposure acts as an endocrine disruptor, causing lasting sex-specific metabolic shifts and immune system changes in rats. Women showed cancer-like states, men metabolic syndrome, raising risks for chronic diseases later in life, despite FDA's current safety claims.
A new study reveals AI systems, like GPT-4, can surpass average human creativity on specific tasks, but top humans still outperform AI, especially in complex creative activities. AI is best positioned as a powerful creative assistant, not a replacement.
New research explores how sugar metabolism and proteins like DLK and SARM1 influence neuronal survival, offering potential breakthroughs for treating Parkinson's, brain injuries, and neurodegenerative diseases.
New research shows that 150 minutes of weekly aerobic exercise can reduce brain age by nearly a year in midlife adults, offering a proactive way to protect cognitive health and delay decline.
New study reveals that red blood cells in long-term diabetes patients cause vascular damage. Restoring microRNA-210 levels could serve as a biomarker to predict and prevent early cardiovascular risks.
Stanford Medicine researchers have identified a protein blocker that reverses knee cartilage loss and prevents arthritis, offering a promising non-surgical alternative to joint replacement treatments.
